New drug trial targets painful skin condition
Disease control
Terminated
This study tested whether a drug called izokibep could help people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. It involved 258 participants and compared the drug to a placebo. The trial was terminated, meaning it was stopped early.
Phase: PHASE3 • Sponsor: ACELYRIN Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC